1324
C. E. Ballard, J. P. Morken
PAPER
Compound 14
Acknowledgment
IR: 3606, 3491, 3083, 3054, 2939, 2865, 2362, 2342, 2331, 1731,
1636, 1609, 1463, 1451, 1434, 1422, 1380, 1345, 1326, 1194, 1138,
1065, 1042, 1001, 990, 947, 919 cm–1.
1H NMR (CDCl3): d = 5.81 (ddd, J = 17.9, 11.0, 1.0 Hz, 1 H), 5.46
(dd, J = 17.9, 1.0 Hz, 1 H), 5.40 (dd, J = 11.0, 1.0 Hz, 1 H), 4.23 (d,
J = 11.4 Hz, 1 H), 3.86 (d, J = 11.4 Hz, 1 H), 3.69–3.63 (m, 1 H),
3.12 (br s, 1 H), 2.81 (br s, 1 H), 1.99–1.62 (m, 3 H), 1.50–1.16 (m,
4 H), 0.80 (d, J = 6.7 Hz, 3 H).
This work was supported by the NIH (GM 59417-03). JPM is an Al-
fred P. Sloan Research Fellow and a Packard Foundation Fellow
and thanks AstraZeneca, Bristol-Myers Squib and GlaxoSmithKli-
ne for support.
References
(1) Reviews with representative reactions: (a) Marder, T. B.;
Norman, N. C. Top. Catal. 1998, 5, 63. (b) Suginome, M.;
Ito, Y. Chem. Rev. 2000, 100, 3221. (c) Ishiyama, T.;
Miyaura, N. J. Organomet. Chem. 2000, 611, 392.
(2) (a) Morgan, J. B.; Miller, S. P.; Morken, J. P. J. Am. Chem.
Soc. 2003, 125, 8702. (b) Miller, S. P.; Morgan, J. B.;
Nepveux, F. J. V.; Morken, J. P. Org. Lett. 2004, 6, 131.
(3) Morgan, J. B.; Morken, J. P. Org. Lett. 2003, 5, 2573.
(4) (a) Ishiyama, T.; Masafumi, Y.; Miyaura, N. Chem.
Commun. 1996, 2073. (b) Clegg, W.; Thorsten, J.; Marder,
T. B.; Noman, N. C.; Orpen, A. G.; Peakman, T. M.; Quayle,
M. J.; Rice, C. R.; Scott, A. J. J. Chem. Soc., Dalton Trans.
1998, 1431.
(5) Examples of diastereoselective silaboration/allylboration:
(a) Suginome, M.; Nakamura, H.; Matsuda, T.; Ito, Y. J. Am.
Chem. Soc. 1998, 120, 4248. (b) Suginome, M.; Matsuda,
T.; Yoshimoto, T.; Ito, Y. Org. Lett. 1999, 1, 1567.
(6) (a) Hoffmann, R. W.; Sander, T.; Hense, A. Liebigs Ann.
Chem. 1993, 771. (b) Hoffmann, R. W.; Sander, T. Liebigs
Ann. Chem. 1993, 1185. (c) Watanabe, T.; Sakai, M.;
Miyaura, N.; Suzuki, A. J. Chem. Soc., Chem. Commun.
1994, 467. (d) Ahiko, T.-a.; Ishiyama, T.; Miyaura, N.
Chem. Lett. 1997, 811.
13C NMR (CDCl3): d = 143.0, 116.4, 78.7, 61.5, 48.4, 39.0, 29.6,
29.3, 24.0, 16.0.
HRMS–FAB: m/z [M + Li] calcd for C10H18O2Li: 177.1467; found:
177.1461.
Compound 16
IR: 3946, 3755, 3693, 3157, 3054, 2987, 2686, 2522, 2306, 2256,
1794, 1638, 1561, 1422, 1272, 1158, 1096 cm–1.
1H NMR (CDCl3): d = 6.04 (dd, J = 17.6, 11.0 Hz, 1 H), 5.28 (dd,
J = 17.6, 1.0 Hz, 1 H), 5.23 (dd, J = 11.0, 1.0 Hz, 1 H), 4.26 (dd,
J = 11.6, 3.4 Hz, 1 H), 3.72–3.61 (m, 2 H), 2.50 (d, J = 4.7 Hz, 1 H),
2.33–2.32 (m, 1 H), 1.88–1.87 (m, 1 H), 1.79–1.52 (m, 3 H), 1.25
(s, 1 H), 0.95–0.84 (m, 2 H), 0.85 (d, J = 6.2 Hz, 3 H).
13C NMR (CDCl3): d = 143.8, 114.5, 76.7, 64.7, 45.9, 42.2, 33.5,
30.6, 27.2, 22.2.
Compound 18
IR: 3610, 3502, 3076, 3054, 2939, 2867, 2362, 2342, 2323, 1733,
1684, 1646, 1449, 1439, 1420, 1391, 1200, 1171, 1154, 1048, 1013,
984 cm–1.
1H NMR (CDCl3): d = 4.91 (s, 1 H), 4.79 (s, 1 H), 4.13–4.01 (m, 2
H), 3.78 (dd, J = 11.1, 5.6 Hz, 1 H), 2.58–2.52 (m, 1 H), 2.37 (br s,
2 H), 2.17–2.02 (m, 2 H), 1.86–1.66 (m, 4 H), 1.58–1.47 (m, 1 H).
(7) Cookson, R. C.; Liverton, N. J. J. Chem. Soc., Perkin Trans.
1 1985, 1589.
(8) Smulik, J. A.; Diver, S. T. Org. Lett. 2000, 2, 2271.
(9) Silverstein, R. M.; Bassler, G. C.; Morrill, T. C. In
Spectrometric Identification of Organic Compounds, 5th
ed.; New York: Wiley, 1991, 221.
(10) Cherwinski, W. J.; Johnson, B.; Lewis, J. J. Chem. Soc.,
Dalton Trans. 1974, 1404.
13C NMR (CDCl3): d = 146.2, 110.5, 71.4, 62.3, 50.1, 33.9, 31.8,
23.2.
HRMS–FAB: m/z [M + Li] calcd for C8H14O2Li: 149.1154; found:
149.1157.
Synthesis 2004, No. 9, 1321–1324 © Thieme Stuttgart · New York